title: Scintigraphic demonstration of myocardial perfusion and ischaemia associated with coronary artery bypass grafting.
abstract: OBJECTIVE
  To assess if myocardial perfusion scintigraphy (MPS) at rest can be of value in elucidating myocardial perfusion, ischaemia and perioperative myocardial infarction (PMI) associated with coronary artery bypass graft (CABG) surgery.
  
  
  METHODS
  This was a prospective randomized study of patients undergoing elective CABG. Forty-eight patients in the control group underwent serial ECG recordings and measurements of CK-MB and cTnT. Fifty-four patients in the study group were additionally examined with MPS preoperatively and 2-4 days and 6 weeks postoperatively.
  
  
  RESULTS
  The study showed a highly significant (p < 0.001) improvement in myocardial radionuclide uptake from preoperatively to 2-4 days postoperatively. Judged from ECG and enzymatic changes, two control patients and one study patient only had PMI and no additional cases of PMI were demonstrated by MPS.
  
  
  CONCLUSIONS
  MPS at rest showed that CABG significantly improved myocardial perfusion, by demonstrating an increase in radionuclide uptake. In diagnosing PMI, we found that MPS provided no additional information beyond cardiac biochemical markers and ECG changes.
authors.affiliation: Department of Cardiology, University of Oslo, Ullevål Hospital, Oslo, Norway.
authors.forename: Anne Cecilie K
authors.initials: AC
authors.lastname: Larstorp
authors.forename: Camilla
authors.initials: C
authors.lastname: Lund Søraas
authors.forename: Theis
authors.initials: T
authors.lastname: Tønnessen
authors.forename: Carl
authors.initials: C
authors.lastname: Müller
authors.forename: Sverre E
authors.initials: SE
authors.lastname: Kjeldsen
authors.forename: Arild
authors.initials: A
authors.lastname: Mangschau
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D003326:Coronary Circulation; D052279:Creatine Kinase, MB Form / Q000097:blood; D017558:Elective Surgical Procedures; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D015902:Gamma Cameras; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000000981:diagnostic imaging* / Q000209:etiology / Q000503:physiopathology; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D011446:Prospective Studies; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013997:Time Factors; D016896:Treatment Outcome; D020107:Troponin T / Q000097:blood
chemical_list: D015415:Biomarkers; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; D020107:Troponin T; C078700:technetium tc-99m tetrofosmin; D052279:Creatine Kinase, MB Form